Mark E. Flanagan
Pfizer (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Advanced biosensing and bioanalysis techniques, Antibiotic Resistance in Bacteria, DNA and Nucleic Acid Chemistry, Radical Photochemical Reactions
Most-Cited Works
- → Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor(2003)668 cited
- → Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases(2014)581 cited
- → Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection(2010)332 cited
- → Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors(2014)320 cited
- → Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases(2018)163 cited
- → DNA-encoded chemical libraries(2022)161 cited
- → Expanding Reactivity in DNA-Encoded Library Synthesis via Reversible Binding of DNA to an Inert Quaternary Ammonium Support(2019)148 cited
- → On-DNA Decarboxylative Arylation: Merging Photoredox with Nickel Catalysis in Water(2019)103 cited
- → Employing Photoredox Catalysis for DNA‐Encoded Chemistry: Decarboxylative Alkylation of α‐Amino Acids(2018)102 cited
- → Paper- and computer-based workarounds to electronic health record use at three benchmark institutions(2013)95 cited